Donors for SARS-CoV-2 Convalescent Plasma for a Controlled Clinical Trial: Donor Characteristics, Content and Time Course of SARS-CoV-2 Neutralizing Antibodies

BACKGROUND: Convalescent plasma is one of the treatment options for COVID-19 which is currently being investigated in many clinical trials. Understanding of donor and product characteristics is important for optimization of convalescent plasma. METHODS: Patients who had recovered from CO­VID-19 were...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Transfus Med Hemother
Autores principales: Körper, Sixten, Jahrsdörfer, Bernd, Corman, Victor M., Pilch, Jan, Wuchter, Patrick, Blasczyk, Rainer, Müller, Rebecca, Tonn, Torsten, Bakchoul, Tamam, Schäfer, Richard, Juhl, David, Schwarz, Tatjana, Gödecke, Nina, Burkhardt, Thomas, Schmidt, Michael, Appl, Thomas, Eichler, Hermann, Klüter, Harald, Drosten, Christian, Seifried, Erhard, Schrezenmeier, Hubert
Formato: Artigo
Lenguaje:Inglês
Publicado: S. Karger GmbH 2021
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8216018/
https://ncbi.nlm.nih.gov/pubmed/34177417
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000515610
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares